An off-the-shelf therapy that can be used immediately, rather than one that must be manufactured individually for each patient (such as chimeric antigen receptor T-cell therapies, or CAR-Ts), can be a life-saving treatment for patients who encounter difficult-to-treat or rapidly progressing...
Read More1 min read
Drug Discovery News Special Report: Well CHOsen?
November 4, 2018
Special Report on Cell BiologyWell CHOsen?Ever-more complicated biologics push technical boundaries
Read More1 min read
Obtaining the Optimal Clone: Exploiting metabolic selection in mammalian cells for clonal enrichment, particularly for difficult-to-express proteins.
November 21, 2017
The life sciences industry is increasingly addressing lifethreatening diseases with sophisticated and complex protein therapeutics, such as novel scaffolds, fusion proteins, bi-specific proteins, and cytotoxic cytokines and interferons. These next-generation therapeutics, which are often...
Read More1 min read
Making the Right Choice: Transient vs. Stable Pool Expression in CHO Cells
September 29, 2017
Historically, transient and stable transfections have been performed for different purposes. Transient transfections can rapidly provide reasonable amounts of recombinant proteins (mg quantities) for early evaluation of their activity and typically transient transfections were used in the screening...
Read More